Tipifarnib in Treating Patients With Recurrent or Progressive Malignant Glioma

NCT00005859 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

136

Enrollment

OTHER

Sponsor class

Conditions

Brain and Central Nervous System Tumors

Interventions

DRUG: tipifarnib

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]